Necropsy studies of patients with Parkinson's syndrome show that idiopathic Parkinson's disease (IPD) comprises between 60 and 75% of cases.' 2 In life most of these are correctly diagnosed, but despite the application of stringent diagnostic criteria3 misdiagnoses do occur, with some patients thought clinically to have IPD turning out to have other illnesses. 1 2 4 Conversely, in other patients with atypical clinical pictures the diagnosis of IPD is established only after death.5 6 There are few clinico-pathological studies from which to assess the accuracy of clinical diagnosis but it is estimated at around 80%.2 7 Multiple system atrophy, progressive supranuclear palsy, Alzheimer 
Results
The mean age of disease onset was 64-5 (range 31-85) years, and the mean duration of disease was 11 9 (range 2-35) years; 59 patients were men and 41 were women. Seventy six cases fulfilled the pathological criteria for IPD, while 24 patients were clinically misdiagnosed. There was no significant difference between the two groups for age at onset, age at death, or terminal disease severity ( Neuropathological findings-Lewy bodies were found easily in the substantia nigra of most cases with histological IPD. In a few, where there was severe cell loss, it was necessary to examine more than one section before they were identified. Lewy bodies were also present in the locus coeruleus in 76% (54/7 1) and in the dorsal vagal nucleus in 79% (49/62) of cases where suitable tissue was available for examination. Cortical Lewy bodies were found in all cases with histological IPD, including seven patients in whom the disease duration was 5 years or less. In 58 (76%) they were easily found; nine (12%) required a prolonged search; a further nine (12%) needed ubiquitin staining for identification. A formal study of Lewy body distribution in the different cortical areas was not undertaken. In most cases, however, we found that examination of the anterior cingulate gyrus yielded positive results most quickly. Only one case showed more than five Lewy bodies per field at x 100 magnification, thereby satisfying the recently proposed criteria for diagnosis of diffuse Lewy body disease.12 Cell loss in the substantia nigra, relative to age-matched controls, was estimated as mild in eight (1 %), mild to moderate in 23 (30%), moderate to severe in 30 (39%), and severe in 15 (20%) of cases.
Co-existing striatal pathology was found in 27 (36%) IPD brains; in most there was vascular damage with multiple lacunar infarcts (table 2). Pathology outside of the nigrostriatal system occurred in 19 (22%) cases; in nine (12%) there was co-existent Alzheimer's disease, seven (9%) had vascular damage, and one case had Alzheimer-type pathology.
The principal findings in the 24 cases without Lewy bodies were progressive supranuclear palsy (six; two classical and four atypical), multiple system atrophy (five), Alzheimer's disease (three), Alzheimer-type UK Clinico-pathological correlations in the cases of IPD-For the 76 patients with histological IPD there was a positive correlation between the severity of nigral cell loss and both disease duration (r = 0-31; p = 0-008) and severity at death (r = 0 39; p = 0001). There was also a positive correlation between the duration of disease and severity at death (r = 0-34; p = 0 003) and between cell loss in the substantia nigra and the locus coeruleus (r = 0-38; p = 0002). In 54 (71 %) patients the cause of death was known. All correlations were greatest for the 46% (26/54) of patients who died from causes clearly unrelated to their IPD (for example, myocardial infarction, stroke, cancer). The r value for the correlation between nigral cell loss and disease duration in this group increased to 0-52 (p = 001).
Discussion
The concept of Parkinson's disease is historically a clinical one stemming from James Parkinson's'3 seminal description which was later embellished by the nineteenth century neurologists Charcot and Gowers. Many authorities have drawn attention to the difficulties in distinguishing Parkinson's disease clinically from other parkinsonian syndromes. Progress in this area has been hampered by the failure to apply rigid clinical criteria and sparse clinical documentation in published pathological series.'4 Furthermore, how much disease classification relied on pathological criteria such as severity of nigral cell loss or the presence of Lewy bodies, is unclear.
In our study 76% of cases satisfied the established neuropathological criteria for IPD. Despite the guideline PDSBB criteria for the clinical diagnosis of IPD3 those used by individual neurologists clearly differed. Nevertheless, each patient included in this study had been specifically considered during life to have IPD rather than a less well-defined parkinsonian syndrome. The retrospective application of the recommended diagnostic criteria' improved the diagnostic accuracy to 82% (73/89); 16 of the 24 cases misdiagnosed, however, still fulfilled these criteria and three others with atypical clinical features had typical Lewy body pathology.
The occurrence of cortical Lewy bodies in all cases of IPD has not been previously reported. Our finding suggests the causative agent of IPD produces damage beyond the confines of those nuclei regularly reported as being involved-for example, substantia nigra, substantia innominata, locus coeruleus, dorsal vagal nucleus. We suggest that the widespread distribution of Lewy bodies may reflect a "field change" in certain neuronal types, one of which may be cells synthesising tyrosine hydroxylase, which have recently been identified in the cerebral cortex.'6 Whether Lewy bodies are formed primarily at a specific sitefor example, the substantia nigra-with later development elsewhere is not known, but our findings of widespread Lewy bodies in patients with short disease duration suggest concurrent formation may occur.
An unexpected finding was the high incidence of Alzheimer's disease and Alzheimertype pathology which had been diagnosed clinically as IPD. Extrapyramidal signs in Alzheimer's disease are well reported and have in part been attributed to the severity of cell loss in the substantia nigra. '7 18 In previous reports, however, it has been suggested that these patients are easily distinguishable from those with IPD.'9 Our findings suggest that such a distinction cannot always be made. Furthermore, we wish to draw attention to those patients with a parkinsonian syndrome and Alzheimer-type pathology, who may represent cases of "preclinical" Alzheimer's disease. 20 In both groups the preponderance of striatal plaques and cell loss in the substantia nigra may together have contributed to the extrapyramidal features.
We have confirmed previous reports correlating nigral cell loss with disease duration and severity"5 21 
